Amended Patent Bill Limits Opportunities For “Second Window” Review

A new version of patent reform legislation would allow a patent to be challenged anytime during its life, but set stricter requirements for requesting a review after the first year

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet